Rise and shine, another day is on the way. And as always, we expect this will be a busy one. To prepare, yes, we are brewing our treasured cup of stimulation - our flavor today is Cinnamon Cream Swirl - and munching on banana bread prepared by our own Mrs. Pharmalot. This will help us tackle our ever-growing to-do list. We trust you can relate. So here are a few tidbits to get you going. Hope you day goes well and you conquer the world...
Amgen Shuts Epogen Manufacturing In California Plant (Longmont Times-Call)
AstraZeneca Pays $135M For Equal Say In Amylin Drugs (Reuters)
Amgen Ends Pancreatic Drug Study On Panel Recommendation (Dow Jones)
Novo Nordisk Raises Targets For Victoza And Insulin Demand (Reuters)
Merck Places Combo Cholesterol Drug On Hold (Dow Jones)
Strides May Sell Injectable Drug Unit (Bloomberg News)
Lilly Head-To-Head Forteo Study Showed No Difference (Wall Street Journal)
Pfizer Wants To Demolish Old Groton R&D Building (The Day)
FDA Approves Three New Doggie Drugs (Veterinary Practice News)
EDITOR'S NOTE: Please check this post for updates during the day
sunrise pic thx to benimoto on flickr